fenofibrate has been researched along with Triple Negative Breast Neoplasms in 1 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T | 1 |
| Zhang, Q | 1 |
| Zhang, J | 1 |
| Yang, G | 1 |
| Shao, Z | 1 |
| Luo, J | 1 |
| Fan, M | 1 |
| Ni, C | 1 |
| Wu, Z | 1 |
| Hu, X | 1 |
1 other study available for fenofibrate and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease | 2014 |